Read more
1:55 PM · 20 November 2025

Chart of the day: US100 (20.11.2025)

US100
Indices
-
-
Nvidia
Stocks
NVDA.US, NVIDIA Corp
-
-

Nvidia delivered another outstanding report, beating expectations with USD 57 billion in Q3 revenue (+62% y/y) and issuing an exceptionally strong USD 65 billion forecast for Q4. Management addressed all major bearish arguments — from supply constraints to demand durability — emphasizing the feasibility of USD 500 billion in combined Blackwell + Rubin revenue by 2026. The optimistic tone and record data-center sales triggered a strong positive reaction across global equity markets linked to AI.

The results immediately improved market sentiment. US100 (Nasdaq 100) rebounded by around 2.00%, reversing some of the recent declines as AI and semiconductor stocks rallied in tandem. Nvidia shares themselves jumped 5–5.5% in pre-market trading to USD 196 per share. AMD, Broadcom and Intel also gained; Asian chipmakers such as Samsung and Foxconn recorded strong increases earlier in the day. The improved risk appetite spilled over into a short-term rebound in the cryptocurrency market as well.

Nvidia was the primary catalyst for markets, but short-term investor focus is now shifting toward upcoming macro data. The market expects the NFP report to be released later today, which could influence the Fed’s December rate decision. For now, however, Nvidia’s results have clearly lifted sentiment, easing concerns about an “AI bubble” and driving a broad-based recovery.

20 November 2025, 2:22 AM

NVIDIA Beats Expectations: The AI Powerhouse Saving the Future

19 November 2025, 11:07 PM

BREAKING: FOMC minutes - many against December cut!

19 November 2025, 10:52 PM

Daily Summary: Market attempts recovery, all hope in Nvidia

19 November 2025, 9:46 PM

Constellation Energy and Three Mile Island — Nuclear Past and Future

The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.

Join over 2 000 000 investors from around the world